# Effects of Psilocybin in Major Depressive Disorder

> **NCT03181529** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 27 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT03181529
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-10
- **Primary completion:** 2020-12-02
- **Final completion:** 2020-12-02
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03181529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03181529, "Effects of Psilocybin in Major Depressive Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03181529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*